Composition and method for treating glaucoma
US6369116B1 · kind B1 · utility
207Cited by
12References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 23, 1998 |
| Grant date | Apr 9, 2002 |
| Priority date | — |
| Expiry date | Dec 23, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Implants and methods are provided for modulating wound healing and controlling infection to improve the success of glaucoma filtration surgery. Formulations of one or more therapeutically active agents and a biodegradable polymer provide a substantially constant rate of release for an extended period of time.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.